Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705795200 on November 29, 2007

J. Biol. Chem., Vol. 283, Issue 5, 2973-2985, February 1, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/5/2973    most recent
M705795200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, D. P.
Right arrow Articles by Schwinn, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, D. P.
Right arrow Articles by Schwinn, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The {alpha}1a-Adrenergic Receptor Occupies Membrane Rafts with Its G Protein Effectors but Internalizes via Clathrin-coated Pits*Formula

Daniel P. Morris{ddagger}1, Beilei Lei{ddagger}, Yue-Xuan Wu{ddagger}, Gregory A. Michelotti{ddagger}, and Debra A. Schwinn§

From the {ddagger}Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710 and the §Department of Anesthesiology, Pharmacology, and Genome Sciences, University of Washington, Seattle, Washington 98195

The {alpha}1a-adrenergic receptor ({alpha}1aAR) occupies intracellular and plasma membranes in both native and heterologous expression systems. Based on multiple independent lines of evidence, we demonstrate the {alpha}1aAR at the cell surface occupies membrane rafts but exits from rafts following stimulation. In non-detergent raft preparations, basal {alpha}1aAR is present in low density membrane rafts and colocalizes with its G protein effectors on density gradients. Raft disruption by cholesterol depletion with methyl-β-cyclodextrin eliminates these light rafts. To confirm the presence of the {alpha}1aAR in plasma membrane rafts, fluorescence resonance energy transfer measurements were used to demonstrate colocalization of surface receptor and the raft marker, cholera toxin B. This colocalization was largely lost following {alpha}1aAR stimulation with phenylephrine. Similarly, receptor stimulation causes exit of the {alpha}1aAR from light rafts within 3-10 min in contrast to the G proteins, which largely remain in light rafts. Importantly, this delayed exit of the {alpha}1aAR suggests acute receptor signaling and desensitization occur entirely within rafts. Interestingly, both confocal analysis and measurement of surface {alpha}1aAR levels indicate modest receptor internalization during the 10 min following stimulation, suggesting most of the receptor has entered non-raft plasma membrane. Nevertheless, activation does increase the rate of receptor internalization as does disruption of rafts with methyl-β-cyclodextrin, suggesting raft exit enables internalization. Confocal analysis of surface-labeled hemagglutinin-{alpha}1aAR reveals that basal and stimulated receptor occupies clathrin pits in fixed cells consistent with previous indirect evidence. The evidence presented here strongly suggests the {alpha}1aAR is a lipid raft protein under basal conditions and implies agonist-mediated signaling occurs from rafts.


Received for publication, July 16, 2007 , and in revised form, November 29, 2007.

* This work was supported in part by National Institutes of Health Grant HL49103 (to D. A. S.) and American Heart Association Grant 0530175N (to D. P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. s1-s6 and a movie.

1 To whom correspondence should be addressed: 595 LaSalle St., Ste. 1027, Durham, NC 27710. Tel.: 919-681-4780; Fax: 919-681-4776; E-mail: morri082{at}mc.duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
Y. Heakal and M. Kester
Nanoliposomal Short-Chain Ceramide Inhibits Agonist-Dependent Translocation of Neurotensin Receptor 1 to Structured Membrane Microdomains in Breast Cancer Cells
Mol. Cancer Res., May 1, 2009; 7(5): 724 - 734.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Stanasila, L. Abuin, J. Dey, and S. Cotecchia
Different Internalization Properties of the {alpha}1a- and {alpha}1b-Adrenergic Receptor Subtypes: The Potential Role of Receptor Interaction with {beta}-Arrestins and AP50
Mol. Pharmacol., September 1, 2008; 74(3): 562 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. O. Rybin, J. Guo, Z. Gertsberg, S. J. Feinmark, and S. F. Steinberg
Phorbol 12-Myristate 13-Acetate-dependent Protein Kinase C{delta}-Tyr311 Phosphorylation in Cardiomyocyte Caveolae
J. Biol. Chem., June 27, 2008; 283(26): 17777 - 17788.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement